Type Two Diabetes ~ NewsWire

Tests for Type 1 Diabetes, Type 2 Diabetes, and Prediabetes. Your doctor will have you take one or more of the following blood tests to confirm the This measures your blood sugar before and after you drink a liquid that contains glucose. You'll fast (not eat) overnight before the test and have your blood...Type 2 diabetes accounts for 90 to 95 percent of all diabetes cases, and it usually develops after the age of 40, so yes you are right. Diabetes can be of two types: Type 1 diabetes: in this kind of diabetes the insulin is not made in the body because of the damage to the beta cells of the pancreas.Type 2 diabetes is a long-term medical condition in which your body doesn't use insulin properly, resulting in unusual People with type 2 diabetes are said to have insulin resistance. People who are middle-aged or older Usually, a combination of things causes type 2 diabetes. They might includeType 2 diabetes usually appears after age 40, but people of all ages, even children, can develop it. The U.S. Preventive Services Task Force recommends that adults ages 40 to 70 who are obese or overweight have their blood glucose checked at least every 3 years as long as their results are normal.About type 2 diabetes. Diabetes is usually a lifelong condition that causes a person's blood Four of the main risk factors for developing type 2 diabetes are: age - being over the age of 40 (over 25 for Type 2 diabetes is up to six times more common in south Asian communities than in the general UK...

Type 2 diabetes usually appears after age 40. - Brainly.com

Type 2 diabetes occurs mainly in people aged over 40. The first-line treatment is diet, weight control and physical activity. The good news is that many people can stay well using However if the blood sugar (glucose) level remains high then tablets to reduce the blood glucose level are usually advised.Type 2 diabetes is an impairment in the way the body regulates and uses sugar (glucose) as a fuel. This long-term (chronic) condition results in too much sugar circulating in the bloodstream. Eventually, high blood sugar levels can lead to disorders of the circulatory, nervous and immune systems.People usually develop type 2 diabetes after the age of 40 years, although people of South Asian origin are at an increased risk of the condition and may develop diabetes from the age of 25 onwards. The condition is also becoming increasingly common among children and adolescents across all...Type 2 diabetes (T2D), formerly known as adult-onset diabetes, is a form of diabetes that is characterized by high blood sugar, insulin resistance, and relative lack of insulin.

Type 2 Diabetes: Symptoms, Causes, Diagnosis, and Treatment

Type 2 diabetes usually begins after the age of 40, but is now affecting more children and adolescents, due to obesity affecting more and Because type 2 diabetes is rarely accompanied by symptoms in the early stages, it is often discovered incidentally during a routine medical examination.Diabetes can affect people of any age. But managing type 2 diabetes can become more complicated as you get older. Here are a few things you might notice about your type 2 diabetes around age 50, and steps you can take to keep it under control. Your symptoms may be different. As you get older...The prevalence of type 2 diabetes continues to increase steadily as more people live longer and grow heavier. Both diabetes and older age are major risk factors for coronary heart disease (CHD). It is therefore not surprising that CHD is by far the leading cause of death in older patients with diabetes.Although type 2 diabetes is widely diagnosed in adults, its frequency has markedly increased in the pediatric age group since the end of the 20th century. The investigators concluded that early onset type 2 diabetes appears to be a more aggressive disease from a cardiovascular standpoint.Type 1 diabetes usually develops in childhood or at a young age. Type 1 diabetes is a result of a damaged pancreas that leaves the organ producing either very The severity of diabetes can vary quite a bit: Some people only have to make minor changes to their lifestyle after they are diagnosed.

Jump to navigation Jump to search

Type 2 diabetesOther namesDiabetes mellitus type 2;adult-onset diabetes;[1]noninsulin-dependent diabetes mellitus (NIDDM)Universal blue circle image for diabetes[2]Pronunciation/daɪəbiːtəs/ SpecialtyEndocrinologySymptomsIncreased thirst, common urination, unexplained weight loss, larger starvation[3]ComplicationsHyperosmolar hyperglycemic state, diabetic ketoacidosis, center disease, strokes, diabetic retinopathy, kidney failure, amputations[1][4][5]Usual onsetMiddle or older age[6]DurationLong term[6]CausesObesity, loss of exercise, genetics[1][6]Diagnostic wayBlood take a look at[3]PreventionMaintaining standard weight, exercising, eating correctly[1]TreatmentDietary adjustments, metformin, insulin, bariatric surgical treatment[1][7][8][9]Prognosis10 12 months shorter lifestyles expectancy[10]Frequency392 million (2015)[11]

Type 2 diabetes (T2D), formerly referred to as adult-onset diabetes, is a form of diabetes that is characterized through top blood sugar, insulin resistance, and relative loss of insulin.[6] Common symptoms include greater thirst, common urination, and unexplained weight loss.[3] Symptoms might also come with higher starvation, feeling tired, and sores that do not heal.[3] Often signs come on slowly.[6] Long-term complications from top blood sugar come with center disease, strokes, diabetic retinopathy which can result in blindness, kidney failure, and deficient blood float in the limbs which would possibly result in amputations.[1] The sudden onset of hyperosmolar hyperglycemic state might occur; alternatively, ketoacidosis is unusual.[4][5]

Type 2 diabetes essentially occurs because of weight problems and lack of workout.[1] Some persons are more genetically in danger than others.[6]

Type 2 diabetes makes up about 90% of instances of diabetes, with the other 10% due basically to type 1 diabetes and gestational diabetes.[1] In type 1 diabetes there's a decrease general stage of insulin to regulate blood glucose, due to an autoimmune precipitated loss of insulin-producing beta cells within the pancreas.[12][13] Diagnosis of diabetes is by way of blood checks akin to fasting plasma glucose, oral glucose tolerance test, or glycated hemoglobin (A1C).[3]

Type 2 diabetes is largely preventable by means of staying a typical weight, exercising often, and consuming a nutritious diet (prime in vegatables and fruits and coffee in sugar and saturated fats).[1] Treatment comes to workout and nutritional changes.[1] If blood sugar levels don't seem to be adequately lowered, the medicine metformin is normally advisable.[7][14] Many other people might in the end also require insulin injections.[9] In the ones on insulin, robotically checking blood sugar levels is suggested; then again, this might not be needed in those taking capsules.[15]Bariatric surgery frequently improves diabetes in those who are overweight.[8][16]

Rates of type 2 diabetes have greater markedly since 1960 in parallel with obesity.[17] As of 2015 there have been roughly 392 million people diagnosed with the disease compared to around 30 million in 1985.[11][18] Typically it begins in center or older age,[6] even if rates of type 2 diabetes are increasing in young people.[19][20] Type 2 diabetes is related to a ten-year-shorter existence expectancy.[10] Diabetes was one of the most first illnesses ever described, courting back to an Egyptian manuscript from c. 1500 BCE.[21] The importance of insulin within the illness was once decided in the Nineteen Twenties.[22]

Signs and symptoms

Overview of the most significant signs of diabetes.

The classic signs of diabetes are common urination (polyuria), increased thirst (polydipsia), greater starvation (polyphagia), and weight reduction.[23] Other signs which are often present at analysis come with a historical past of blurred imaginative and prescient, itchiness, peripheral neuropathy, recurrent vaginal infections, and fatigue.[13] Other symptoms might include loss of style.[24] Many other folks, then again, have no symptoms all over the first few years and are recognized on routine testing.[13] A small choice of people with type 2 diabetes can expand a hyperosmolar hyperglycemic state (a situation of very prime blood sugar related to a decreased stage of awareness and occasional blood drive).[13]

Complications Main article: Complications of diabetes

Type 2 diabetes is typically a chronic illness associated with a ten-year-shorter existence expectancy.[10] This is partially because of a variety of headaches with which it is related, together with: two to 4 occasions the danger of heart problems, together with ischemic heart illness and stroke; a 20-fold increase in decrease limb amputations, and greater charges of hospitalizations.[10] In the advanced international, and increasingly elsewhere, type 2 diabetes is the biggest explanation for nontraumatic blindness and kidney failure.[25] It has also been related to an larger menace of cognitive disorder and dementia through disease processes reminiscent of Alzheimer's disease and vascular dementia.[26] Other headaches include hyperpigmentation of pores and skin (acanthosis nigricans), sexual disorder, and common infections.[23] There is also an affiliation between type 2 diabetes and gentle hearing loss.[27]

Causes

The development of type 2 diabetes is brought about by way of a mixture of lifestyle and genetic components.[25][28] While some of these components are underneath personal control, such as diet and weight problems, different components aren't, akin to increasing age, female gender, and genetics.[10] Obesity is extra not unusual in women than men in lots of parts of Africa.[29] The dietary status of a mom all the way through fetal development might also play a role, with one proposed mechanism being that of DNA methylation.[30] The intestinal bacteria Prevotella copri and Bacteroides vulgatus had been connected with type 2 diabetes.[31]

Lifestyle Main article: Lifestyle reasons of type 2 diabetes

Lifestyle components are necessary to the advance of type 2 diabetes, together with obesity and being overweight (defined through a frame mass index of greater than 25), lack of bodily task, poor vitamin, stress, and urbanization.[10][32] Excess frame fats is related to 30% of cases in the ones of Chinese and Japanese descent, 60–80% of cases in the ones of European and African descent, and 100% of instances in Pima Indians and Pacific Islanders.[13] Among those who don't seem to be overweight, a high waist–hip ratio is ceaselessly provide.[13] Smoking appears to extend the chance of type 2 diabetes.[33] A lack of sleep has additionally been connected to type 2 diabetes.[34] Laboratory studies have linked short-term sleep deprivations to adjustments in glucose metabolism, fearful machine task, or hormonal factors that can lead to diabetes.[34]

Dietary factors additionally affect the danger of developing type 2 diabetes. Consumption of sugar-sweetened beverages in extra is related to an larger menace.[35][36] The type of fat in the vitamin are vital, with saturated fat and trans fatty acids expanding the danger, and polyunsaturated and monounsaturated fat reducing the danger.[28] Eating numerous white rice appears to play a task in increasing threat.[37] A lack of exercise is thought to reason 7% of instances.[38]Persistent organic pollutants may also play a task.[39]

Genetics Main article: Genetic reasons of type 2 diabetes

Most circumstances of diabetes contain many genes, with every being a small contributor to an increased likelihood of becoming a type 2 diabetic.[10] The proportion of diabetes this is inherited is estimated at 72%.[40] More than 36 genes and 80 unmarried nucleotide polymorphisms (SNPs) have been discovered that give a contribution to the chance of type 2 diabetes.[41][42] All of those genes in combination nonetheless simplest account for 10% of the entire heritable element of the illness.[41] The TCF7L2 allele, for example, increases the risk of developing diabetes by means of 1.5 occasions and is the greatest threat of the common genetic variants.[13] Most of the genes connected to diabetes are all for pancreatic beta cell functions.[13]

There are a variety of rare circumstances of diabetes that arise because of an abnormality in one gene (known as monogenic kinds of diabetes or "other specific types of diabetes").[10][13] These include adulthood onset diabetes of the young (MODY), Donohue syndrome, and Rabson–Mendenhall syndrome, among others.[10] Maturity onset diabetes of the younger represent 1–5% of all circumstances of diabetes in younger other people.[43]

Medical stipulations

There are plenty of drugs and different well being issues that may predispose to diabetes.[44] Some of the medications come with: glucocorticoids, thiazides, beta blockers, odd antipsychotics,[45] and statins.[46] Those who have previously had gestational diabetes are at a better threat of creating type 2 diabetes.[23] Other well being issues which can be related come with: acromegaly, Cushing's syndrome, hyperthyroidism, pheochromocytoma, and certain cancers equivalent to glucagonomas.[44] Individuals with cancer could also be at the next menace of mortality if additionally they have diabetes.[47]Testosterone deficiency may be associated with type 2 diabetes.[48][49]Eating issues may also interact with type 2 diabetes, with bulimia nervosa increasing the risk and anorexia nervosa decreasing it.[50]

Pathophysiology

Type 2 diabetes is due to insufficient insulin manufacturing from beta cells within the environment of insulin resistance.[13] Insulin resistance, which is the lack of cells to respond adequately to normal levels of insulin, happens essentially throughout the muscle tissue, liver, and fats tissue.[51] In the liver, insulin most often suppresses glucose liberate. However, within the environment of insulin resistance, the liver inappropriately releases glucose into the blood.[10] The share of insulin resistance as opposed to beta mobile dysfunction differs among people, with some having primarily insulin resistance and just a minor defect in insulin secretion and others with slight insulin resistance and basically a lack of insulin secretion.[13]

Other potentially vital mechanisms related to type 2 diabetes and insulin resistance come with: larger breakdown of lipids inside of fat cells, resistance to and loss of incretin, high glucagon levels within the blood, higher retention of salt and water via the kidneys, and irrelevant legislation of metabolism through the central apprehensive system.[10] However, now not all other people with insulin resistance develop diabetes since an impairment of insulin secretion by means of pancreatic beta cells is also required.[13]

In the early phases of insulin resistance, the mass of beta cells expands, increasing the output of insulin to catch up on the insulin insensitivity.[52] But when type 2 diabetes has become manifest, a type 2 diabetic will have misplaced about part in their beta cells.[52]Fatty acids in the beta cells activate FOXO1, leading to apoptosis of the beta cells.[52]

Diagnosis

WHO diabetes diagnostic standards[53][54] Condition 2-hour glucose Fasting glucose HbA1cUnit mmol/L mg/dL mmol/L mg/dL mmol/mol DCCT % Normal < 7.8 < 140 < 6.1 < 110 < 42 < 6.0 Impaired fasting glycaemia < 7.8 < 140 6.1–7.0 110–125 42–46 6.0–6.4 Impaired glucose tolerance ≥ 7.8 ≥ 140 < 7.0 < 126 42–46 6.0–6.4 Diabetes mellitus ≥ 11.1 ≥ 200 ≥ 7.0 ≥ 126 ≥ 48 ≥ 6.5

The World Health Organization definition of diabetes (each type 1 and type 2) is for a single raised glucose studying with symptoms, another way raised values on two occasions, of either:[55]

fasting plasma glucose ≥ 7.0 mmol/l (126 mg/dl)orwith a glucose tolerance test, two hours after the oral dose a plasma glucose ≥ 11.1 mmol/l (200 mg/dl)

A random blood sugar of more than 11.1 mmol/l (200 mg/dl) in association with standard symptoms[23] or a glycated hemoglobin (HbA1c) of ≥ 48 mmol/mol (≥ 6.Five DCCT %) is every other manner of diagnosing diabetes.[10] In 2009 an International Expert Committee that incorporated representatives of the American Diabetes Association (ADA), the International Diabetes Federation (IDF), and the European Association for the Study of Diabetes (EASD) recommended that a threshold of ≥ 48 mmol/mol (≥ 6.5 DCCT %) must be used to diagnose diabetes.[56] This advice used to be followed via the American Diabetes Association in 2010.[57] Positive tests will have to be repeated except the person items with conventional symptoms and blood sugars >11.1 mmol/l (>200 mg/dl).[56]

ADA diabetes diagnostic criteria in 2015[58] Diabetes mellitus Prediabetes HbA1c ≥6.5% 5.7-6.4% Fasting glucose ≥126 mg/dL 100-One hundred twenty five mg/dL 2h glucose ≥200 mg/dL 140-199 mg/dL Random glucose with vintage symptoms ≥Two hundred mg/dL Not to be had

Threshold for prognosis of diabetes is in keeping with the relationship between result of glucose tolerance tests, fasting glucose or HbA1c and complications reminiscent of retinal problems.[10] A fasting or random blood sugar is most well-liked over the glucose tolerance take a look at, as they are more handy for other people.[10] HbA1c has the advantages that fasting is not required and effects are extra solid however has the drawback that the take a look at is more costly than measurement of blood glucose.[59] It is estimated that 20% of people with diabetes in the United States don't realize that they have got the illness.[10]

Type 2 diabetes is characterised by prime blood glucose within the context of insulin resistance and relative insulin deficiency.[60] This is against this to type 1 diabetes in which there is an absolute insulin deficiency because of destruction of islet cells within the pancreas and gestational diabetes that may be a new onset of top blood sugars related to pregnancy.[13] Type 1 and type 2 diabetes can in most cases be prominent in keeping with the presenting circumstances.[56] If the prognosis is doubtful antibody checking out could also be useful to verify type 1 diabetes and C-peptide ranges could also be helpful to verify type 2 diabetes,[61] with C-peptide ranges customary or high in type 2 diabetes, however low in type 1 diabetes.[62]

Screening

No major organization recommends common screening for diabetes as there is not any proof that this type of program support results.[63][64] Screening is advisable by means of the United States Preventive Services Task Force (USPSTF) in adults without signs whose blood pressure is greater than 135/80 mmHg.[65] For those whose blood power is less, the evidence is inadequate to suggest for or against screening.[65] There is not any proof that it changes the risk of dying in this group of folks.[64] They also suggest screening amongst those who are overweight and between the ages of 40 and 70.[66]

The World Health Organization recommends testing those teams at top menace[63] and in 2014 the USPSTF is considering a identical recommendation.[67] High-risk groups within the United States come with: those over 45 years old; the ones with a primary degree relative with diabetes; some ethnic groups, together with Hispanics, African-Americans, and Native-Americans; a historical past of gestational diabetes; polycystic ovary syndrome; extra weight; and prerequisites related to metabolic syndrome.[23] The American Diabetes Association recommends screening those who have a BMI over 25 (in people of Asian descent screening is recommended for a BMI over 23).[68]

Prevention

Main article: Prevention of type 2 diabetes

Onset of type 2 diabetes may also be behind schedule or avoided through right kind vitamin and common workout.[69][70] Intensive way of life measures may scale back the chance through over part.[25][71] The advantage of workout happens irrespective of the individual's preliminary weight or subsequent weight loss.[72] High levels of bodily activity cut back the danger of diabetes by way of about 28%.[73] Evidence for the benefit of nutritional changes on my own, then again, is proscribed,[74] with some proof for a vitamin prime in green leafy greens[75] and some for restricting the consumption of sugary drinks.[76] There is an association between higher intake of sugar-sweetened fruit juice and diabetes, but no proof of an affiliation with 100% fruit juice.[77] A 2019 assessment discovered proof of benefit from dietary fiber.[78]

In those with impaired glucose tolerance, diet and exercise either by myself or in combination with metformin or acarbose would possibly decrease the danger of developing diabetes.[25][79] Lifestyle interventions are more effective than metformin.[25] A 2017 review discovered that, longer term, way of life adjustments diminished the risk by 28%, whilst medication does not reduce threat after withdrawal.[80] While low nutrition D ranges are related to an larger threat of diabetes, correcting the levels by means of supplementing nutrition D3 does not toughen that threat.[81]

Management

Further knowledge: Diabetes control

Management of type 2 diabetes specializes in lifestyle interventions, lowering different cardiovascular risk elements, and keeping up blood glucose levels in the commonplace vary.[25] Self-monitoring of blood glucose for folks with newly recognized type 2 diabetes could also be utilized in combination with training,[82] although the good thing about self-monitoring in those no longer using multi-dose insulin is questionable.[25] In those who don't need to measure blood ranges, measuring urine ranges is also accomplished.[82] Managing other cardiovascular risk components, comparable to hypertension, top cholesterol, and microalbuminuria, improves a person's life expectancy.[25] Decreasing the systolic blood pressure to not up to 140 mmHg is associated with a decrease risk of death and better results.[83] Intensive blood power control (less than 130/80 mmHg) versus usual blood power management (not up to 140-160 mmHg systolic to 85–A hundred mmHg diastolic) results in a slight lower in stroke threat however no impact on overall risk of death.[84]

Intensive blood sugar lowering (HbA1c<6%) as opposed to same old blood sugar decreasing (HbA1c of 7–7.9%) does not seem to change mortality.[85][86] The function of treatment is normally an HbA1c of 7 to eight% or a fasting glucose of less than 7.2 mmol/L (130 mg/dl); alternatively those goals may be changed after skilled clinical consultation, allowing for specific risks of hypoglycemia and existence expectancy.[68][87][88] Hypoglycemia is associated with opposed outcomes in older folks with type 2 diabetes.[89] Despite pointers recommending that extensive blood sugar keep an eye on be in line with balancing rapid harms with long-term advantages, many of us – for instance folks with a life expectancy of lower than 9 years who won't get advantages, are over-treated.[90]

It is advisable that every one other folks with type 2 diabetes get common eye examinations.[13] There is vulnerable evidence suggesting that treating gum disease via scaling and root planing might result in a small non permanent growth in blood sugar ranges for other people with diabetes.[91] There is no proof to suggest that this improvement in blood sugar levels is maintained longer than 4 months.[91] There could also be no longer sufficient evidence to determine if drugs to treat gum illness are effective at decreasing blood sugar ranges.[91]

Lifestyle Exercise

A right kind vitamin and common workout are foundations of diabetic care,[23] with one assessment indicating that a greater quantity of exercise stepped forward results.[92] Regular exercise might make stronger blood sugar control, lower frame fat content material, and decrease blood lipid ranges.[93]

Diet

A diabetic nutrition which incorporates calorie restriction to promote weight loss is usually really useful.[94][58] Other recommendations come with emphasizing intake of end result, vegetables, decreased saturated fat and low-fat dairy products, and with a macronutrient consumption tailored to the individual, to distribute calories and carbohydrates all over the day.[58][95] Several diets may be effective such as the Dietary Approaches to Stop Hypertension (DASH), Mediterranean nutrition, low-fat diet, or monitored carbohydrate diets reminiscent of a low carbohydrate nutrition.[58][96][97]Viscous fiber dietary supplements is also helpful in the ones with diabetes.[98]

Vegetarian diets typically had been related to decrease diabetes risk, however don't offer advantages when compared with diets which allow moderate amounts of animal merchandise.[99] There is not enough evidence to signify that cinnamon improves blood sugar levels in people with type 2 diabetes.[100]

Culturally suitable schooling would possibly help other people with type 2 diabetes regulate their blood sugar ranges, for up to 24 months.[101] If changes in lifestyle in those with mild diabetes has now not resulted in improved blood sugars inside six weeks, drugs must then be regarded as.[23] There isn't sufficient proof to resolve if lifestyle interventions affect mortality in those who have already got DM2.[71]

As of 2015, there's inadequate knowledge to suggest nonnutritive sweeteners, however word they are going to help scale back caloric consumption.[102]

Medications Metformin 500mg capsules. Blood sugar keep an eye on See additionally: Anti-diabetic drugs

There are several classes of anti-diabetic medications to be had. Metformin is in most cases recommended as a primary line treatment as there may be some evidence that it decreases mortality;[7][25][103] on the other hand, this conclusion is wondered.[104] Metformin will have to not be used in the ones with critical kidney or liver problems.[23]

A second oral agent of every other elegance or insulin is also added if metformin isn't enough after three months.[87] Other classes of medications include: sulfonylureas, thiazolidinediones, dipeptidyl peptidase-4 inhibitors, SGLT2 inhibitors, and glucagon-like peptide-1 analogs.[87] As of 2015 there used to be no significant distinction between those agents.[87] A 2018 assessment discovered that SGLT2 inhibitors and GLP-1 agonists, but now not DPP-4 inhibitors, had been associated with lower mortality than placebo or no remedy.[105]

Rosiglitazone, a thiazolidinedione, has not been found to fortify long-term outcomes even if it improves blood sugar levels.[106] Additionally it's related to larger charges of heart disease and loss of life.[107]

Injections of insulin may either be added to oral medication or used on my own.[25] Most other folks don't to begin with want insulin.[13] When it's used, a long-acting method is most often added at night time, with oral medications being persisted.[23][25] Doses are then higher to impact (blood sugar ranges being well controlled).[25] When nightly insulin is inadequate, two times day-to-day insulin would possibly achieve higher keep watch over.[23] The long performing insulins glargine and detemir are equally safe and efficient,[108] and do not appear much better than impartial protamine Hagedorn (NPH) insulin, but as they're significantly dearer, they aren't cost effective as of 2010.[109] In those that are pregnant, insulin is typically the remedy of choice.[23]

Blood power reducing

Many international tips suggest blood drive treatment objectives which can be lower than 140/90 mmHg for other folks with diabetes.[110] However, there may be best restricted evidence regarding what the decrease objectives should be. A 2016 systematic evaluate discovered potential harm to treating to goals lower than A hundred and forty mmHg,[111] and a next assessment in 2019 found no evidence of extra benefit from blood drive lowering to between 130 - 140mmHg, even supposing there was an larger threat of inauspicious events.[112]

2015 American Diabetes Association recommendations are that people with diabetes and albuminuria should receive an inhibitor of the renin-angiotensin machine to cut back the dangers of progression to end-stage renal disease, cardiovascular occasions, and death.[113] There is some evidence that angiotensin changing enzyme inhibitors (ACEIs) are awesome to different inhibitors of the renin-angiotensin system reminiscent of angiotensin receptor blockers (ARBs),[114] or aliskiren in combating heart problems.[115] Although a more recent overview discovered identical effects of ACEIs and ARBs on major cardiovascular and renal results.[116] There isn't any evidence that combining ACEIs and ARBs supplies additional advantages.[116]

Other

The use of aspirin to stop cardiovascular disease in diabetes is controversial.[113] Aspirin is advisable in people at top menace of heart problems, however routine use of aspirin has now not been found to reinforce outcomes in clear-cut diabetes.[117] 2015 American Diabetes Association recommendations for aspirin use (in response to professional consensus or scientific enjoy) are that low-dose aspirin use is cheap in adults with diabetes who are at intermediate risk of heart problems (10-year heart problems risk, 5–10%).[113]

Vitamin D supplementation to folks with type 2 diabetes would possibly support markers of insulin resistance and HbA1c.[118]

Surgery

Weight loss surgical procedure in those that are overweight is a good measure to regard diabetes.[119] Many are ready to care for commonplace blood sugar ranges with very little medicine following surgical treatment[120] and long-term mortality is diminished.[121] There alternatively is a few short-term mortality menace of less than 1% from the surgical procedure.[122] The body mass index cutoffs for when surgical operation is acceptable don't seem to be but clear.[121] It is recommended that this selection be thought to be in those that are not able to get each their weight and blood sugar underneath control.[123][124]

Epidemiology

Regional charges of diabetes using data from 195 international locations in 2014

Globally as of 2015 it was estimated that there were 392 million other people with type 2 diabetes making up about 90% of diabetes cases.[10][11] This is similar to about 6% of the world's inhabitants.[11] Diabetes is common both within the developed and the growing international.[10] It stays unusual, however, the least bit evolved international locations.[13]

Women appear to be at a better menace as do positive ethnic teams,[10][125] reminiscent of South Asians, Pacific Islanders, Latinos, and Native Americans.[23] This is also due to enhanced sensitivity to a Western way of life in sure ethnic groups.[126] Traditionally thought to be a disease of adults, type 2 diabetes is increasingly more diagnosed in youngsters in parallel with rising weight problems rates.[10] Type 2 diabetes is now identified as often as type 1 diabetes in teenagers in the United States.[13]

Rates of diabetes in 1985 have been estimated at 30 million, increasing to 135 million in 1995 and 217 million in 2005.[18] This building up is believed to be primarily because of the global inhabitants aging, a decrease in workout, and increasing charges of obesity.[18] The 5 nations with the best selection of other people with diabetes as of 2000 are India having 31.7 million, China 20.8 million, the United States 17.7 million, Indonesia 8.4 million, and Japan 6.8 million.[127] It is known as a global epidemic through the World Health Organization.[1]

History

Further knowledge: History of diabetes

Diabetes is one of the first sicknesses described[21] with an Egyptian manuscript from c. 1500 BCE mentioning "too great emptying of the urine."[128] The first described instances are believed to be of type 1 diabetes.[128] Indian physicians around the same time recognized the illness and labeled it as madhumeha or honey urine noting that the urine would attract ants.[128] The term "diabetes" or "to pass through" used to be first used in 230 BCE via the Greek Apollonius Memphites.[128] The illness used to be uncommon throughout the time of the Roman empire with Galen commenting that he had simplest noticed two circumstances throughout his career.[128]

Type 1 and type 2 diabetes had been recognized as separate prerequisites for the first time via the Indian physicians Sushruta and Charaka in 400–500 AD with type 1 associated with early life and type 2 with being obese.[128] Effective remedy was no longer advanced until the early part of the 20 th century when the Canadians Frederick Banting and Charles Best came upon insulin in 1921 and 1922.[128] This was once followed by the development of the lengthy performing NPH insulin in the 1940s.[128]

In 1916, Elliot Joslin proposed that in other people with diabetes, classes of fasting are helpful.[129] Subsequent analysis has supported this, and weight reduction is a primary line treatment in type 2 diabetes.[129]

References

^ a b c d e f g h i j ok .mw-parser-output cite.citationfont-style:inherit.mw-parser-output .quotation qquotes:"\"""\"""'""'".mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free abackground:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")appropriate 0.1em center/9px no-repeat.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .quotation .cs1-lock-registration abackground:linear-gradient(clear,clear),url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em middle/9px no-repeat.mw-parser-output .id-lock-subscription a,.mw-parser-output .quotation .cs1-lock-subscription abackground:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")correct 0.1em heart/9px no-repeat.mw-parser-output .cs1-subscription,.mw-parser-output .cs1-registrationcolor:#555.mw-parser-output .cs1-subscription span,.mw-parser-output .cs1-registration spanborder-bottom:1px dotted;cursor:assist.mw-parser-output .cs1-ws-icon abackground:linear-gradient(clear,clear),url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em center/12px no-repeat.mw-parser-output code.cs1-codecolor:inherit;background:inherit;border:none;padding:inherit.mw-parser-output .cs1-hidden-errorshow:none;font-size:100%.mw-parser-output .cs1-visible-errorfont-size:100%.mw-parser-output .cs1-maintshow:none;color:#33aa33;margin-left:0.3em.mw-parser-output .cs1-formatfont-size:95%.mw-parser-output .cs1-kern-left,.mw-parser-output .cs1-kern-wl-leftpadding-left:0.2em.mw-parser-output .cs1-kern-right,.mw-parser-output .cs1-kern-wl-rightpadding-right:0.2em.mw-parser-output .quotation .mw-selflinkfont-weight:inherit"Diabetes Fact sheet N°312". World Health Organization. August 2011. Archived from the unique on 26 August 2013. Retrieved 2012-01-09. ^ "Diabetes Blue Circle Symbol". International Diabetes Federation. 17 March 2006. Archived from the unique on 5 August 2007. ^ a b c d e "Diagnosis of Diabetes and Prediabetes". National Institute of Diabetes and Digestive and Kidney Diseases. June 2014. Archived from the unique on 6 March 2016. Retrieved 10 February 2016. ^ a b Pasquel FJ, Umpierrez GE (November 2014). "Hyperosmolar hyperglycemic state: a historic review of the clinical presentation, diagnosis, and treatment". Diabetes Care. 37 (11): 3124–31. doi:10.2337/dc14-0984. PMC 4207202. PMID 25342831. ^ a b Fasanmade OA, Odeniyi IA, Ogbera AO (June 2008). "Diabetic ketoacidosis: diagnosis and management". African Journal of Medicine and Medical Sciences. 37 (2): 99–105. PMID 18939392. ^ a b c d e f g "Causes of Diabetes". National Institute of Diabetes and Digestive and Kidney Diseases. June 2014. Archived from the unique on 2 February 2016. Retrieved 10 February 2016. ^ a b c Maruthur NM, Tseng E, Hutfless S, Wilson LM, Suarez-Cuervo C, Berger Z, Chu Y, Iyoha E, Segal JB, Bolen S (June 2016). "Diabetes Medications as Monotherapy or Metformin-Based Combination Therapy for Type 2 Diabetes: A Systematic Review and Meta-analysis". Annals of Internal Medicine. 164 (11): 740–51. doi:10.7326/M15-2650. PMID 27088241. S2CID 32016657. ^ a b Cetinkunar S, Erdem H, Aktimur R, Sozen S (June 2015). "Effect of bariatric surgery on humoral control of metabolic derangements in obese patients with type 2 diabetes mellitus: How it works". World Journal of Clinical Cases. 3 (6): 504–9. doi:10.12998/wjcc.v3.i6.504. PMC 4468896. PMID 26090370. ^ a b Krentz AJ, Bailey CJ (February 2005). "Oral antidiabetic agents: current role in type 2 diabetes mellitus". Drugs. 65 (3): 385–411. doi:10.2165/00003495-200565030-00005. PMID 15669880. S2CID 29670619. ^ a b c d e f g h i j okay l m n o p q r s Melmed, Shlomo; Polonsky, Kenneth S.; Larsen, P. Reed; Kronenberg, Henry M., eds. (2011). Williams textbook of endocrinology (twelfth ed.). Philadelphia: Elsevier/Saunders. pp. 1371–1435. ISBN 978-1-4377-0324-5. ^ a b c d Vos T, Allen C, Arora M, Barber RM, Bhutta ZA, Brown A, et al. (GBD 2015 Disease and Injury Incidence and Prevalence Collaborators) (October 2016). "Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577. PMID 27733282. ^ MacKay, Ian; Rose, Noel, eds. (2014). The Autoimmune Diseases. Academic Press. p. 575. ISBN 978-0-123-84929-8. OCLC 965646175. ^ a b c d e f g h i j okay l m n o p q Gardner, David G.; Shoback, Dolores, eds. (2011). "Chapter 17: Pancreatic hormones & diabetes mellitus". Greenspan's elementary & medical endocrinology (ninth ed.). New York: McGraw-Hill Medical. ISBN 978-0-07-162243-1. OCLC 613429053. ^ Saenz A, Fernandez-Esteban I, Mataix A, Ausejo M, Roque M, Moher D (July 2005). Saenz A (ed.). "Metformin monotherapy for type 2 diabetes mellitus". The Cochrane Database of Systematic Reviews (3): CD002966. doi:10.1002/14651858.CD002966.pub3. PMID 16034881. (Retracted) ^ Malanda UL, Welschen LM, Riphagen II, Dekker JM, Nijpels G, Bot SD (January 2012). "Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin". The Cochrane Database of Systematic Reviews. 1: CD005060. doi:10.1002/14651858.CD005060.pub3. hdl:1871/48558. PMID 22258959. ^ Ganguly S, Tan HC, Lee PC, Tham KW (April 2015). "Metabolic bariatric surgery and type 2 diabetes mellitus: an endocrinologist's perspective". Journal of Biomedical Research. 29 (2): 105–11. doi:10.7555/JBR.29.20140127. PMC 4389109. PMID 25859264. ^ Moscou, Susan (2013). "Getting the word out: advocacy, social marketing, and policy development and enforcement". In Truglio-Londrigan, Marie; Lewenson, Sandra B. (eds.). Public well being nursing: practicing population-based care (2nd ed.). Burlington, MA: Jones & Bartlett Learning. p. 317. ISBN 978-1-4496-4660-8. OCLC 758391750. ^ a b c Smyth S, Heron A (January 2006). "Diabetes and obesity: the twin epidemics". Nature Medicine. 12 (1): 75–80. doi:10.1038/nm0106-75. PMID 16397575. S2CID 1042625. ^ Tfayli H, Arslanian S (March 2009). "Pathophysiology of type 2 diabetes mellitus in youth: the evolving chameleon". Arquivos Brasileiros de Endocrinologia e Metabologia. 53 (2): 165–74. doi:10.1590/s0004-27302009000200008. PMC 2846552. PMID 19466209. ^ Imperatore G, Boyle JP, Thompson TJ, Case D, Dabelea D, Hamman RF, Lawrence JM, Liese AD, Liu LL, Mayer-Davis EJ, Rodriguez BL, Standiford D (December 2012). "Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth". Diabetes Care. 35 (12): 2515–20. doi:10.2337/dc12-0669. PMC 3507562. PMID 23173134. ^ a b Leutholtz BC, Ripoll I (2011). "Diabetes". Exercise and disease management (2d ed.). Boca Raton: CRC Press. p. 25. ISBN 978-1-4398-2759-8. OCLC 725919496. ^ Zaccardi F, Webb DR, Yates T, Davies MJ (February 2016). "Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective". Postgraduate Medical Journal. 92 (1084): 63–9. doi:10.1136/postgradmedj-2015-133281. PMID 26621825. S2CID 28169759. ^ a b c d e f g h i j okay l Vijan S (March 2010). "In the clinic. Type 2 diabetes". Annals of Internal Medicine. 152 (5): ITC31–15, quiz ITC316. doi:10.7326/0003-4819-152-5-201003020-01003. PMID 20194231. S2CID 207535925. ^ Rathee, Manu; Jain, Prachi (2019). "Ageusia". StatPearls. StatPearls Publishing. ^ a b c d e f g h i j okay l Ripsin CM, Kang H, Urban RJ (January 2009). "Management of blood glucose in type 2 diabetes mellitus". American Family Physician. 79 (1): 29–36. PMID 19145963. ^ Pasquier F (October 2010). "Diabetes and cognitive impairment: how to evaluate the cognitive status?". Diabetes & Metabolism. 36 Suppl 3: S100-5. doi:10.1016/S1262-3636(10)70475-4. PMID 21211730. ^ Akinpelu, Olubunmi V.; Mujica-Mota, Mario; Daniel, Sam J. (March 2014). "Is type 2 diabetes mellitus associated with alterations in hearing? A systematic review and meta-analysis". The Laryngoscope. 124 (3): 767–776. doi:10.1002/lary.24354. ISSN 1531-4995. PMID 23945844. S2CID 25569962. ^ a b Risérus U, Willett WC, Hu FB (January 2009). "Dietary fats and prevention of type 2 diabetes". Progress in Lipid Research. 48 (1): 44–51. doi:10.1016/j.plipres.2008.10.002. PMC 2654180. PMID 19032965. ^ Hilawe, Esayas Haregot; Yatsuya, Hiroshi; Kawaguchi, Leo; Aoyama, Atsuko (1 September 2013). "Differences by sex in the prevalence of diabetes mellitus, impaired fasting glycaemia and impaired glucose tolerance in sub-Saharan Africa: a systematic review and meta-analysis". Bulletin of the World Health Organization. 91 (9): 671–682D. doi:10.2471/BLT.12.113415. PMC 3790213. PMID 24101783. ^ Christian P, Stewart CP (March 2010). "Maternal micronutrient deficiency, fetal development, and the risk of chronic disease". The Journal of Nutrition. 140 (3): 437–45. doi:10.3945/jn.109.116327. PMID 20071652. ^ Pedersen HK, Gudmundsdottir V, Nielsen HB, Hyotylainen T, Nielsen T, Jensen BA, et al. (July 2016). "Human gut microbes impact host serum metabolome and insulin sensitivity". Nature. 535 (7612): 376–81. Bibcode:2016Natur.535..376P. doi:10.1038/nature18646. PMID 27409811. S2CID 4459808. ^ Abdullah A, Peeters A, de Courten M, Stoelwinder J (September 2010). "The magnitude of association between overweight and obesity and the risk of diabetes: a meta-analysis of prospective cohort studies". Diabetes Research and Clinical Practice. 89 (3): 309–19. doi:10.1016/j.diabres.2010.04.012. PMID 20493574. ^ Pan A, Wang Y, Talaei M, Hu FB, Wu T (December 2015). "Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysis". The Lancet. Diabetes & Endocrinology. 3 (12): 958–67. doi:10.1016/S2213-8587(15)00316-2. PMC 4656094. PMID 26388413. ^ a b Touma C, Pannain S (August 2011). "Does lack of sleep cause diabetes?". Cleveland Clinic Journal of Medicine. 78 (8): 549–58. doi:10.3949/ccjm.78a.10165. PMID 21807927. S2CID 45708828. ^ Malik VS, Popkin BM, Bray GA, Després JP, Hu FB (March 2010). "Sugar-sweetened beverages, obesity, type 2 diabetes mellitus, and cardiovascular disease risk". Circulation. 121 (11): 1356–64. doi:10.1161/CIRCULATIONAHA.109.876185. PMC 2862465. PMID 20308626. ^ Malik VS, Popkin BM, Bray GA, Després JP, Willett WC, Hu FB (November 2010). "Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis". Diabetes Care. 33 (11): 2477–83. doi:10.2337/dc10-1079. PMC 2963518. PMID 20693348. ^ Hu EA, Pan A, Malik V, Sun Q (March 2012). "White rice consumption and risk of type 2 diabetes: meta-analysis and systematic review". BMJ. 344: e1454. doi:10.1136/bmj.e1454. PMC 3307808. PMID 22422870. ^ Lee IM, Shiroma EJ, Lobelo F, Puska P, Blair SN, Katzmarzyk PT (July 2012). "Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy". Lancet. 380 (9838): 219–29. doi:10.1016/S0140-6736(12)61031-9. PMC 3645500. PMID 22818936. ^ Lind L, Lind PM (June 2012). "Can persistent organic pollutants and plastic-associated chemicals cause cardiovascular disease?". Journal of Internal Medicine. 271 (6): 537–53. doi:10.1111/j.1365-2796.2012.02536.x. PMID 22372998. S2CID 41018361. ^ Willemsen, Gonneke; Ward, Kirsten J.; Bell, Christopher G.; Christensen, Kaare; Bowden, Jocelyn; Dalgård, Christine; Harris, Jennifer R.; Kaprio, Jaakko; Lyle, Robert; Magnusson, Patrik Ok. E.; Mather, Karen A. (December 2015). "The Concordance and Heritability of Type 2 Diabetes in 34,166 Twin Pairs From International Twin Registers: The Discordant Twin (DISCOTWIN) Consortium". Twin Research and Human Genetics. 18 (6): 762–771. doi:10.1017/thg.2015.83. ISSN 1832-4274. PMID 26678054. ^ a b Herder C, Roden M (June 2011). "Genetics of type 2 diabetes: pathophysiologic and clinical relevance". European Journal of Clinical Investigation. 41 (6): 679–92. doi:10.1111/j.1365-2362.2010.02454.x. PMID 21198561. S2CID 43548816. ^ Fuchsberger, Christian; Flannick, Jason; Teslovich, Tanya M.; Mahajan, Anubha; Agarwala, Vineeta; Gaulton, Kyle J.; Ma, Clement; Fontanillas, Pierre; Moutsianas, Loukas; McCarthy, Davis J.; Rivas, Manuel A. (4 August 2016). "The genetic architecture of type 2 diabetes". Nature. 536 (7614): 41–47. Bibcode:2016Natur.536...41F. doi:10.1038/nature18642. ISSN 1476-4687. PMC 5034897. PMID 27398621. ^ "Monogenic Forms of Diabetes: Neonatal Diabetes Mellitus and Maturity-onset Diabetes of the Young". National Diabetes Information Clearinghouse (NDIC). National Institute of Diabetes and Digestive and Kidney Diseases, NIH. March 2007. Archived from the unique on 2008-07-04. Retrieved 2008-08-04. ^ a b Funnell MM, Anderson RM (2008). "Influencing self-management: from compliance to collaboration". In Feinglos MN, Bethel MA (eds.). Type 2 diabetes mellitus: an evidence-based approach to practical control. Contemporary endocrinology. Totowa, NJ: Humana Press. p. 462. ISBN 978-1-58829-794-5. OCLC 261324723. ^ Izzedine H, Launay-Vacher V, Deybach C, Bourry E, Barrou B, Deray G (November 2005). "Drug-induced diabetes mellitus". Expert Opinion on Drug Safety. 4 (6): 1097–109. doi:10.1517/14740338.4.6.1097. PMID 16255667. S2CID 21532595. ^ Sampson UK, Linton MF, Fazio S (July 2011). "Are statins diabetogenic?". Current Opinion in Cardiology. 26 (4): 342–7. doi:10.1097/HCO.0b013e3283470359. PMC 3341610. PMID 21499090. ^ Giovannucci, E.; Harlan, D. M.; Archer, M. C.; Bergenstal, R. M.; Gapstur, S. M.; Habel, L. A.; Pollak, M.; Regensteiner, J. G.; Yee, D. (29 June 2010). "Diabetes and Cancer: A consensus report". Diabetes Care (Professional society guidelines). 33 (7): 1674–1685. doi:10.2337/dc10-0666. PMC 2890380. PMID 20587728. ^ Saad F, Gooren L (March 2009). "The role of testosterone in the metabolic syndrome: a review". The Journal of Steroid Biochemistry and Molecular Biology. 114 (1–2): 40–3. doi:10.1016/j.jsbmb.2008.12.022. PMID 19444934. S2CID 22222112. ^ Farrell JB, Deshmukh A, Baghaie AA (2008). "Low testosterone and the association with type 2 diabetes". The Diabetes Educator. 34 (5): 799–806. doi:10.1177/0145721708323100. PMID 18832284. ^ Nieto-Martínez, R; González-Rivas, JP; Medina-Inojosa, JR; Florez, H (22 November 2017). "Are Eating Disorders Risk Factors for Type 2 Diabetes? A Systematic Review and Meta-analysis". Current Diabetes Reports (Systematic evaluation and meta-analysis). 17 (12): 138. doi:10.1007/s11892-017-0949-1. ISSN 1539-0829. PMID 29168047. S2CID 3688434. ^ Diabetes mellitus a information to patient care. Philadelphia: Lippincott Williams & Wilkins. 2007. p. 15. ISBN 978-1-58255-732-8. ^ a b c Sun T, Han X (2019). "Death versus dedifferentiation: The molecular bases of beta cell mass reduction in type 2 diabetes". Seminars in Cell and Developmental Biology. 103: 76–82. doi:10.1016/j.semcdb.2019.12.002. PMID 31831356. ^ Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: Report of a WHO/IDF consultation (PDF). Geneva: World Health Organization. 2006. p. 21. ISBN 978-92-4-159493-6. ^ Vijan, S (March 2010). "Type 2 diabetes". Annals of Internal Medicine. 152 (5): ITC31-15. doi:10.7326/0003-4819-152-5-201003020-01003. PMID 20194231. ^ World Health Organization. "Definition, diagnosis and classification of diabetes mellitus and its complications: Report of a WHO Consultation. Part 1. Diagnosis and classification of diabetes mellitus". Archived from the original on 2007-05-29. Retrieved 2007-05-29. ^ a b c International Expert Committee (July 2009). "International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes". Diabetes Care. 32 (7): 1327–34. doi:10.2337/dc09-9033. PMC 2699715. PMID 19502545. ^ American Diabetes Association (January 2010). "Diagnosis and classification of diabetes mellitus". Diabetes Care. 33 Suppl 1 (Supplement_1): S62-9. doi:10.2337/dc10-S062. PMC 2797383. PMID 20042775. ^ a b c d Fox, Caroline S.; Golden, Sherita Hill; Anderson, Cheryl; Bray, George A.; Burke, Lora E.; de Boer, Ian H.; Deedwania, Prakash; Eckel, Robert H.; Ershow, Abby G.; Fradkin, Judith; Inzucchi, Silvio E.; Kosiborod, Mikhail; Nelson, Robert G.; Patel, Mahesh J.; Pignone, Michael; Quinn, Laurie; Schauer, Philip R.; Selvin, Elizabeth; Vafiadis, Dorothea Ok. (September 2015). "Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association". Diabetes Care (Professional society guidelines). 38 (9): 1777–1803. doi:10.2337/dci15-0012. PMC 4876675. PMID 26246459. ^ American Diabetes Association (January 2012). "Diagnosis and classification of diabetes mellitus". Diabetes Care. 35 Suppl 1 (Suppl 1): S64-71. doi:10.2337/dc12-s064. PMC 3632174. PMID 22187472. ^ Kumar, Vinay; Fausto, Nelson; Abbas, Abul Ok.; Cotran, Ramzi S.; Robbins, Stanley L. (2005). Robbins and Cotran Pathologic Basis of Disease (seventh ed.). Philadelphia, Pa.: Saunders. pp. 1194–95. ISBN 978-0-7216-0187-8. ^ Diabetes mellitus a guide to affected person care. Philadelphia: Lippincott Williams & Wilkins. 2007. p. 201. ISBN 978-1-58255-732-8. ^ Vivian EM, Blackorbay B (2013). "Chapter 13: Endocrine Disorders". In Lee M (ed.). Basic Skills in Interpreting Laboratory Data (5th ed.). Bethesda, MD: American Society of Health-System Pharmacists. ISBN 978-1-58528-345-3. OCLC 859778842. ^ a b Valdez R (July 2009). "Detecting undiagnosed type 2 diabetes: family history as a risk factor and screening tool". Journal of Diabetes Science and Technology. 3 (4): 722–6. doi:10.1177/193229680900300417. PMC 2769984. PMID 20144319. ^ a b Selph S, Dana T, Blazina I, Bougatsos C, Patel H, Chou R (June 2015). "Screening for type 2 diabetes mellitus: a systematic review for the U.S. Preventive Services Task Force". Annals of Internal Medicine. 162 (11): 765–76. doi:10.7326/M14-2221. PMID 25867111. ^ a b "Archived: Diabetes Mellitus (Type 2) in Adults: Screening". U.S. Preventive Services Task Force. June 2008. Archived from the original on 2014-02-07. Retrieved 2014-03-16. ^ Siu AL (December 2015). "Screening for Abnormal Blood Glucose and Type 2 Diabetes Mellitus: U.S. Preventive Services Task Force Recommendation Statement". Annals of Internal Medicine. 163 (11): 861–8. doi:10.7326/M15-2345. PMID 26501513. ^ "Draft Recommendation Statement Screening for Abnormal Glucose and Type 2 Diabetes Mellitus". U.S. Preventive Services Task Force. Archived from the original on 9 October 2014. Retrieved 7 October 2014. ^ a b "Standards of medical care in diabetes--2015: summary of revisions". Diabetes Care. 38 Suppl (38): S4. January 2015. doi:10.2337/dc15-S003. PMID 25537706. ^ Raina Elley C, Kenealy T (December 2008). "Lifestyle interventions reduced the long-term risk of diabetes in adults with impaired glucose tolerance". Evidence-Based Medicine. 13 (6): 173. doi:10.1136/ebm.13.6.173. PMID 19043031. S2CID 26714233. ^ Hemmingsen, Bianca; Gimenez-Perez, Gabriel; Mauricio, Didac; Roqué I Figuls, Marta; Metzendorf, Maria-Inti; Richter, Bernd (4 December 2017). "Diet, physical activity or both for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus". The Cochrane Database of Systematic Reviews. 12: CD003054. doi:10.1002/14651858.CD003054.pub4. ISSN 1469-493X. PMC 6486271. PMID 29205264. ^ a b Schellenberg ES, Dryden DM, Vandermeer B, Ha C, Korownyk C (October 2013). "Lifestyle interventions for patients with and at risk for type 2 diabetes: a systematic review and meta-analysis". Annals of Internal Medicine. 159 (8): 543–51. doi:10.7326/0003-4819-159-8-201310150-00007. PMID 24126648. ^ O'Gorman DJ, Krook A (September 2011). "Exercise and the treatment of diabetes and obesity". The Medical Clinics of North America. 95 (5): 953–69. doi:10.1016/j.mcna.2011.06.007. PMID 21855702. ^ Kyu HH, Bachman VF, Alexander LT, Mumford JE, Afshin A, Estep K, Veerman JL, Delwiche Okay, Iannarone ML, Moyer ML, Cercy Okay, Vos T, Murray CJ, Forouzanfar MH (August 2016). "Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013". BMJ. 354: i3857. doi:10.1136/bmj.i3857. PMC 4979358. PMID 27510511. ^ Nield L, Summerbell CD, Hooper L, Whittaker V, Moore H (July 2008). Nield L (ed.). "Dietary advice for the prevention of type 2 diabetes mellitus in adults". The Cochrane Database of Systematic Reviews (3): CD005102. doi:10.1002/14651858.CD005102.pub2. hdl:10149/92337. PMID 18646120. S2CID 23039006. (Retracted) ^ Carter P, Gray LJ, Troughton J, Khunti Okay, Davies MJ (August 2010). "Fruit and vegetable intake and incidence of type 2 diabetes mellitus: systematic review and meta-analysis". BMJ. 341: c4229. doi:10.1136/bmj.c4229. PMC 2924474. PMID 20724400. ^ Schwingshackl, Lukas; Hoffmann, Georg; Lampousi, Anna-Maria; Knüppel, Sven; Iqbal, Khalid; Schwedhelm, Carolina; Bechthold, Angela; Schlesinger, Sabrina; Boeing, Heiner (2017-04-10). "Food groups and risk of type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies". European Journal of Epidemiology. 32 (5): 363–375. doi:10.1007/s10654-017-0246-y. ISSN 0393-2990. PMC 5506108. PMID 28397016. ^ Xi B, Li S, Liu Z, Tian H, Yin X, Huai P, Tang W, Zhou D, Steffen LM (2014). "Intake of fruit juice and incidence of type 2 diabetes: a systematic review and meta-analysis". PLOS ONE. 9 (3): e93471. Bibcode:2014PLoSO...993471X. doi:10.1371/magazine.pone.0093471. PMC 3969361. PMID 24682091. ^ Reynolds A, Mann J, Cummings J, Winter N, Mete E, Te Morenga L (February 2019). "Carbohydrate quality and human health: a series of systematic reviews and meta-analyses". Lancet. 393 (10170): 434–445. doi:10.1016/S0140-6736(18)31809-9. PMID 30638909. S2CID 58632705. ^ Santaguida PL, Balion C, Hunt D, Morrison Ok, Gerstein H, Raina P, Booker L, Yazdi H (August 2005). "Diagnosis, prognosis, and treatment of impaired glucose tolerance and impaired fasting glucose" (PDF). Evidence Report/Technology Assessment (128): 1–11. PMC 4780988. PMID 16194123. Archived from the unique (PDF) on 2008-09-10. ^ Haw JS, Galaviz KI, Straus AN, Kowalski AJ, Magee MJ, Weber MB, Wei J, Narayan KM, Ali MK (December 2017). "Long-term Sustainability of Diabetes Prevention Approaches: A Systematic Review and Meta-analysis of Randomized Clinical Trials". JAMA Internal Medicine. 177 (12): 1808–1817. doi:10.1001/jamainternmed.2017.6040. PMC 5820728. PMID 29114778. ^ Seida JC, Mitri J, Colmers IN, Majumdar SR, Davidson MB, Edwards AL, Hanley DA, Pittas AG, Tjosvold L, Johnson JA (October 2014). "Clinical review: Effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis". The Journal of Clinical Endocrinology and Metabolism. 99 (10): 3551–60. doi:10.1210/jc.2014-2136. PMC 4483466. PMID 25062463. ^ a b "Type 2 diabetes: The management of type 2 diabetes". May 2009. Archived from the original on 2015-05-22. ^ Emdin CA, Rahimi K, Neal B, Callender T, Perkovic V, Patel A (February 2015). "Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis". JAMA. 313 (6): 603–15. doi:10.1001/jama.2014.18574. PMID 25668264. ^ McBrien K, Rabi DM, Campbell N, Barnieh L, Clement F, Hemmelgarn BR, Tonelli M, Leiter LA, Klarenbach SW, Manns BJ (September 2012). "Intensive and Standard Blood Pressure Targets in Patients With Type 2 Diabetes Mellitus: Systematic Review and Meta-analysis". Archives of Internal Medicine. 172 (17): 1296–303. doi:10.1001/archinternmed.2012.3147. PMID 22868819. ^ Boussageon R, Bejan-Angoulvant T, Saadatian-Elahi M, Lafont S, Bergeonneau C, Kassaï B, Erpeldinger S, Wright JM, Gueyffier F, Cornu C (July 2011). "Effect of intensive glucose lowering treatment on all cause mortality, cardiovascular death, and microvascular events in type 2 diabetes: meta-analysis of randomised controlled trials". BMJ. 343: d4169. doi:10.1136/bmj.d4169. PMC 3144314. PMID 21791495. ^ Webster MW (July 2011). "Clinical practice and implications of recent diabetes trials". Current Opinion in Cardiology. 26 (4): 288–93. doi:10.1097/HCO.0b013e328347b139. PMID 21577100. S2CID 20819316. ^ a b c d Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, Peters AL, Tsapas A, Wender R, Matthews DR (March 2015). "Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes". Diabetologia. 58 (3): 429–42. doi:10.1007/s00125-014-3460-0. PMID 25583541. ^ Qaseem A, Wilt TJ, Kansagara D, Horwitch C, Barry MJ, Forciea MA (April 2018). "Hemoglobin A1c Targets for Glycemic Control With Pharmacologic Therapy for Nonpregnant Adults With Type 2 Diabetes Mellitus: A Guidance Statement Update From the American College of Physicians". Annals of Internal Medicine. 168 (8): 569–576. doi:10.7326/M17-0939. PMID 29507945. ^ Seaquist, E. R.; Anderson, J.; Childs, B.; Cryer, P.; Dagogo-Jack, S.; Fish, L.; Heller, S. R.; Rodriguez, H.; Rosenzweig, J.; Vigersky, R. (15 April 2013). "Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society". Diabetes Care (Professional society tips). 36 (5): 1384–1395. doi:10.2337/dc12-2480. PMC 3631867. PMID 23589542. ^ Makam AN, Nguyen OK (January 2017). "An Evidence-Based Medicine Approach to Antihyperglycemic Therapy in Diabetes Mellitus to Overcome Overtreatment". Circulation. 135 (2): 180–195. doi:10.1161/CIRCULATIONAHA.116.022622. PMC 5502688. PMID 28069712. ^ a b c Simpson TC, Weldon JC, Worthington HV, Needleman I, Wild SH, Moles DR, Stevenson B, Furness S, Iheozor-Ejiofor Z (November 2015). "Treatment of periodontal disease for glycaemic control in people with diabetes mellitus". The Cochrane Database of Systematic Reviews (11): CD004714. doi:10.1002/14651858.CD004714.pub3. PMC 6486035. PMID 26545069. ^ Smith AD, Crippa A, Woodcock J, Brage S (December 2016). "Physical activity and incident type 2 diabetes mellitus: a systematic review and dose-response meta-analysis of prospective cohort studies". Diabetologia. 59 (12): 2527–2545. doi:10.1007/s00125-016-4079-0. PMC 6207340. PMID 27747395. ^ Thomas DE, Elliott EJ, Naughton GA (July 2006). "Exercise for type 2 diabetes mellitus". The Cochrane Database of Systematic Reviews (3): CD002968. doi:10.1002/14651858.CD002968.pub2. PMID 16855995. S2CID 25505640. ^ Davis N, Forbes B, Wylie-Rosett J (June 2009). "Nutritional strategies in type 2 diabetes mellitus". The Mount Sinai Journal of Medicine, New York. 76 (3): 257–68. doi:10.1002/msj.20118. PMID 19421969. ^ Evert, A. B.; Boucher, J. L.; Cypress, M.; Dunbar, S. A.; Franz, M. J.; Mayer-Davis, E. J.; Neumiller, J. J.; Nwankwo, R.; Verdi, C. L.; Urbanski, P.; Yancy, W. S. (19 December 2013). "Nutrition Therapy Recommendations for the Management of Adults With Diabetes". Diabetes Care (Professional society guidelines). 37 (Supplement_1): S120–S143. doi:10.2337/dc14-S120. PMID 24357208. ^ Thomas D, Elliott EJ (January 2009). Thomas D (ed.). "Low glycaemic index, or low glycaemic load, diets for diabetes mellitus". The Cochrane Database of Systematic Reviews (1): CD006296. doi:10.1002/14651858.CD006296.pub2. PMC 6486008. PMID 19160276. ^ Feinman RD, Pogozelski WK, Astrup A, Bernstein RK, Fine EJ, Westman EC, Accurso A, Frassetto L, Gower BA, McFarlane SI, Nielsen JV, Krarup T, Saslow L, Roth KS, Vernon MC, Volek JS, Wilshire GB, Dahlqvist A, Sundberg R, Childers A, Morrison Okay, Manninen AH, Dashti HM, Wood RJ, Wortman J, Worm N (January 2015). "Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base". Nutrition. 31 (1): 1–13. doi:10.1016/j.nut.2014.06.011. PMID 25287761. ^ Jovanovski, E; Khayyat, R; Zurbau, A; Komishon, A; Mazhar, N; Sievenpiper, JL; Blanco Mejia, S; Ho, HVT; Li, D; Jenkins, AL; Duvnjak, L; Vuksan, V (May 2019). "Should Viscous Fiber Supplements Be Considered in Diabetes Control? Results From a Systematic Review and Meta-analysis of Randomized Controlled Trials". Diabetes Care. 42 (5): 755–766. doi:10.2337/dc18-1126. PMID 30617143. S2CID 58665219. ^ Glick-Bauer M, Yeh MC (October 2014). "The health advantage of a vegan diet: exploring the gut microbiota connection". Nutrients (Review). 6 (11): 4822–38. doi:10.3390/nu6114822. PMC 4245565. PMID 25365383. ^ Leach MJ, Kumar S (September 2012). "Cinnamon for diabetes mellitus". The Cochrane Database of Systematic Reviews (9): CD007170. doi:10.1002/14651858.CD007170.pub2. PMC 6486047. PMID 22972104. ^ Attridge M, Creamer J, Ramsden M, Cannings-John R, Hawthorne Okay (September 2014). "Culturally appropriate health education for people in ethnic minority groups with type 2 diabetes mellitus". The Cochrane Database of Systematic Reviews (9): CD006424. doi:10.1002/14651858.CD006424.pub3. PMID 25188210. ^ Gardner, C; Wylie-Rosett, J; Gidding, SS; Steffen, LM; Johnson, RK; Reader, D; Lichtenstein, AH; American Heart Association Nutrition Committee of the Council on Nutrition, Physical Activity and Metabolism, Council on Arteriosclerosis, Thrombosis and Vascular Biology, Council on Cardiovascular Disease in the, Young.; American Diabetes, Association. (August 2012). "Nonnutritive sweeteners: current use and health perspectives: a scientific statement from the American Heart Association and the American Diabetes Association". Diabetes Care (Professional society guidelines). 35 (8): 1798–808. doi:10.2337/dc12-9002. PMC 3402256. PMID 22778165. Lay summary.CS1 maint: more than one names: authors record (link) ^ Palmer SC, Mavridis D, Nicolucci A, Johnson DW, Tonelli M, Craig JC, Maggo J, Gray V, De Berardis G, Ruospo M, Natale P, Saglimbene V, Badve SV, Cho Y, Nadeau-Fredette AC, Burke M, Faruque L, Lloyd A, Ahmad N, Liu Y, Tiv S, Wiebe N, Strippoli GF (July 2016). "Comparison of Clinical Outcomes and Adverse Events Associated With Glucose-Lowering Drugs in Patients With Type 2 Diabetes: A Meta-analysis". JAMA. 316 (3): 313–24. doi:10.1001/jama.2016.9400. PMID 27434443. ^ Boussageon R, Supper I, Bejan-Angoulvant T, Kellou N, Cucherat M, Boissel JP, Kassai B, Moreau A, Gueyffier F, Cornu C (2012). Groop L (ed.). "Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials". PLOS Medicine. 9 (4): e1001204. doi:10.1371/journal.pmed.1001204. PMC 3323508. PMID 22509138. ^ Zheng SL, Roddick AJ, Aghar-Jaffar R, Shun-Shin MJ, Francis D, Oliver N, Meeran K (April 2018). (*2*). JAMA. 319 (15): 1580–1591. doi:10.1001/jama.2018.3024. PMC 5933330. PMID 29677303. ^ Richter B, Bandeira-Echtler E, Bergerhoff Okay, Clar C, Ebrahim SH (July 2007). Richter B (ed.). "Rosiglitazone for type 2 diabetes mellitus" (PDF). The Cochrane Database of Systematic Reviews (3): CD006063. doi:10.1002/14651858.CD006063.pub2. PMC 7389529. PMID 17636824. ^ Chen X, Yang L, Zhai SD (December 2012). "Risk of cardiovascular disease and all-cause mortality among diabetic patients prescribed rosiglitazone or pioglitazone: a meta-analysis of retrospective cohort studies". Chinese Medical Journal. 125 (23): 4301–6. PMID 23217404. ^ Swinnen SG, Simon AC, Holleman F, Hoekstra JB, Devries JH (July 2011). Simon AC (ed.). "Insulin detemir versus insulin glargine for type 2 diabetes mellitus". The Cochrane Database of Systematic Reviews (7): CD006383. doi:10.1002/14651858.CD006383.pub2. PMC 6486036. PMID 21735405. ^ Waugh N, Cummins E, Royle P, Clar C, Marien M, Richter B, Philip S (July 2010). "Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation". Health Technology Assessment. 14 (36): 1–248. doi:10.3310/hta14360. PMID 20646668. ^ Mitchell, Sharon; Malanda, Belma; Damasceno, Albertino; Eckel, Robert H.; Gaita, Dan; Kotseva, Kornelia; Januzzi, James L.; Mensah, George; Plutzky, Jorge; Prystupiuk, Maksym; Ryden, Lars (September 2019). "A Roadmap on the Prevention of Cardiovascular Disease Among People Living With Diabetes". Global Heart. 14 (3): 215–240. doi:10.1016/j.gheart.2019.07.009. ISSN 2211-8179. PMID 31451236. ^ Brunström M, Carlberg B (February 2016). "Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses". BMJ. 352: i717. doi:10.1136/bmj.i717. PMC 4770818. PMID 26920333. ^ Brunström, Mattias; Carlberg, Bo (2019-09-30). "Benefits and harms of lower blood pressure treatment targets: systematic review and meta-analysis of randomised placebo-controlled trials". BMJ Open. 9 (9): e026686. doi:10.1136/bmjopen-2018-026686. ISSN 2044-6055. PMC 6773352. PMID 31575567. ^ a b c Fox, Caroline S.; Golden, Sherita Hill; Anderson, Cheryl; Bray, George A.; Burke, Lora E.; Boer, Ian H. de; Deedwania, Prakash; Eckel, Robert H.; Ershow, Abby G.; Fradkin, Judith; Inzucchi, Silvio E. (2015-09-01). "Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association". Diabetes Care. 38 (9): 1777–1803. doi:10.2337/dci15-0012. ISSN 0149-5992. PMC 4876675. PMID 26246459. ^ Cheng J, Zhang W, Zhang X, Han F, Li X, He X, Li Q, Chen J (May 2014). "Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis". JAMA Internal Medicine. 174 (5): 773–85. doi:10.1001/jamainternmed.2014.348. PMID 24687000. ^ Zheng, Sean L.; Roddick, Alistair J.; Ayis, Salma (September 2017). "Effects of aliskiren on mortality, cardiovascular outcomes and adverse events in patients with diabetes and cardiovascular disease or risk: A systematic review and meta-analysis of 13,395 patients". Diabetes & Vascular Disease Research. 14 (5): 400–406. doi:10.1177/1479164117715854. ISSN 1752-8984. PMC 5600262. PMID 28844155. ^ a b Catalá-López, Ferrán; Macías Saint-Gerons, Diego; González-Bermejo, Diana; Rosano, Giuseppe M.; Davis, Barry R.; Ridao, Manuel; Zaragoza, Abel; Montero-Corominas, Dolores; Tobías, Aurelio; de l. a. Fuente-Honrubia, César; Tabarés-Seisdedos, Rafael (March 2016). "Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-Analyses". PLOS Medicine. 13 (3): e1001971. doi:10.1371/journal.pmed.1001971. ISSN 1549-1676. PMC 4783064. PMID 26954482. ^ Pignone M, Alberts MJ, Colwell JA, Cushman M, Inzucchi SE, Mukherjee D, Rosenson RS, Williams CD, Wilson PW, Kirkman MS (June 2010). "Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation". Diabetes Care. 33 (6): 1395–402. doi:10.2337/dc10-0555. PMC 2875463. PMID 20508233. ^ Mirhosseini N, Vatanparast H, Mazidi M, Kimball SM (September 2017). "The Effect of Improved Serum 25-Hydroxyvitamin D Status on Glycemic Control in Diabetic Patients: A Meta-Analysis". The Journal of Clinical Endocrinology and Metabolism. 102 (9): 3097–3110. doi:10.1210/jc.2017-01024. PMID 28957454. ^ Picot J, Jones J, Colquitt JL, Gospodarevskaya E, Loveman E, Baxter L, Clegg AJ (September 2009). "The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation". Health Technology Assessment. 13 (41): 1–190, 215–357, iii–iv. doi:10.3310/hta13410. hdl:10536/DRO/DU:30064294. PMID 19726018. ^ Frachetti KJ, Goldfine AB (April 2009). "Bariatric surgery for diabetes management". Current Opinion in Endocrinology, Diabetes and Obesity. 16 (2): 119–24. doi:10.1097/MED.0b013e32832912e7. PMID 19276974. S2CID 31797748. ^ a b Schulman AP, del Genio F, Sinha N, Rubino F (September–October 2009). ""Metabolic" surgery for treatment of type 2 diabetes mellitus". Endocrine Practice. 15 (6): 624–31. doi:10.4158/EP09170.RAR. PMID 19625245. ^ Colucci RA (January 2011). "Bariatric surgery in patients with type 2 diabetes: a viable option". Postgraduate Medicine. 123 (1): 24–33. doi:10.3810/pgm.2011.01.2242. PMID 21293081. S2CID 207551737. ^ Dixon JB, le Roux CW, Rubino F, Zimmet P (June 2012). "Bariatric surgery for type 2 diabetes". Lancet. 379 (9833): 2300–11. doi:10.1016/S0140-6736(12)60401-2. PMID 22683132. S2CID 5198462. ^ Rubino F, Nathan DM, Eckel RH, Schauer PR, Alberti KG, Zimmet PZ, Del Prato S, Ji L, Sadikot SM, Herman WH, Amiel SA, Kaplan LM, Taroncher-Oldenburg G, Cummings DE (June 2016). "Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations". Diabetes Care. 39 (6): 861–77. doi:10.2337/dc16-0236. PMID 27222544. ^ Abate N, Chandalia M (2001). "Ethnicity and type 2 diabetes: focus on Asian Indians". Journal of Diabetes and Its Complications. 15 (6): 320–7. doi:10.1016/S1056-8727(01)00161-1. PMID 11711326. ^ Carulli L, Rondinella S, Lombardini S, Canedi I, Loria P, Carulli N (November 2005). "Review article: diabetes, genetics and ethnicity". Alimentary Pharmacology & Therapeutics. 22 Suppl 2: 16–9. doi:10.1111/j.1365-2036.2005.02588.x. PMID 16225465. S2CID 35041696. ^ Wild S, Roglic G, Green A, Sicree R, King H (May 2004). "Global prevalence of diabetes: estimates for the year 2000 and projections for 2030". Diabetes Care. 27 (5): 1047–53. doi:10.2337/diacare.27.5.1047. PMID 15111519. ^ a b c d e f g h Zajac J, Shrestha A, Patel P, Poretsky L (2009). "The Main Events in the History of Diabetes Mellitus". In Poretsky L (ed.). Principles of diabetes mellitus (2nd ed.). New York: Springer. pp. 3–16. ISBN 978-0-387-09840-1. OCLC 663097550. ^ a b Koutroumpakis, E; Jozwik, B; Aguilar, D; Taegtmeyer, H (2020). "Strategies of Unloading the Failing Heart from Metabolic Stress". The American Journal of Medicine (Review). 133 (3): 290–296. doi:10.1016/j.amjmed.2019.08.035. PMC 7054139. PMID 31520618.

External links

Diabetes mellitusat Wikipedia's sister tasksDefinitions from WiktionaryMedia from Wikimedia CommonsNews from WikinewsQuotations from WikiquoteTexts from WikisourceTextbooks from WikibooksResources from Wikiversity Type 2 diabetes at Curlie IDF Diabetes Atlas 2015 National Diabetes Information Clearinghouse Centers for Disease Control (Endocrine pathology) ADA's Standards of Medical Care in Diabetes 2019ClassificationDICD-10: E11ICD-9-CM: 250.00, 250.02OMIM: 125853MeSH: D003924DiseasesDB: 3661External resourcesMedlinePlus: 000313eMedicine: article/117853vteDisease of the pancreas and glucose metabolismDiabetes Types type 1 type 2 gestational MODY 1 2 Three Four 5 6 Complications See Template:DiabetesAbnormal blood glucose ranges Hyperglycaemia Oxyhyperglycemia Hypoglycaemia Whipple's triadInsulin disorders Insulin resistance Hyperinsulinism Rabson–Mendenhall syndromeOther pancreatic problems Insulinoma Insulitis vteDiabetesTypes Type 1 Type 2 LADA Gestational diabetes Diabetes and pregnancy Prediabetes Impaired fasting glucose Impaired glucose tolerance Insulin resistance KPD MODY Neonatal Transient Permanent Type 3c (pancreatogenic) Type 3Blood assessments Blood sugar stage Glycosylated hemoglobin Glucose tolerance take a look at Postprandial glucose check Fructosamine Glucose check C-peptide Noninvasive glucose monitor Insulin tolerance take a look atManagement Diet in diabetes Diabetes medicine Insulin remedy in depth typical pulsatile Cure Embryonic stem cells Artificial pancreas Other Gastric bypass surgical treatmentComplications Diabetic comas Hypoglycemia Ketoacidosis Hyperosmolar hyperglycemic state Diabetic foot ulcer Neuropathic arthropathy Organs in diabetes Blood vessels Muscle Kidney Nerves Retina Heart Diabetes-related pores and skin illness Diabetic dermopathy Diabetic bulla Diabetic cheiroarthropathy Neuropathic ulcer Hyperglycemia HypoglycemiaOther Glossary of diabetes History of diabetes Notable other people with type 1 diabetes Retrieved from "https://en.wikipedia.org/w/index.php?title=Type_2_diabetes&oldid=1014720637"